Septerna, Inc. (SEPN)
31.00
+0.59
(+1.94%)
USD |
NASDAQ |
Jun 09, 16:00
31.00
0.00 (0.00%)
After-Hours: 19:49
Septerna EPS Diluted (Quarterly) : -0.193 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arvinas, Inc. | -0.90 |
| Cocrystal Pharma, Inc. | -0.1668 |
| CNBX Pharmaceuticals, Inc. | 0.00 |
| GB Sciences, Inc. | -- |
| Fulcrum Therapeutics, Inc. | -0.2479 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.637M |
| Revenue (Quarterly) | 26.52M |
| Total Expenses (Quarterly) | 35.16M |
| Enterprise Value | 1.042B |
| Gross Profit Margin (Quarterly) | 98.41% |
| Profit Margin (Quarterly) | -32.56% |
| Earnings Yield | -2.64% |
| Normalized Earnings Yield | -2.635 |